Capital Impact Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $995K | Sell |
|
|||||
|
2023
Q4 | $1.16M | Buy |
|
|||||
|
2023
Q3 | $312K | Hold |
|
|||||
|
2023
Q2 | $494K | Sell |
|
|||||
|
2023
Q1 | $701K | Buy |
|
|||||
|
2022
Q4 | $712K | Sell |
|
|||||
|
2022
Q3 | $570K | Hold |
|
|||||
|
2022
Q2 | $584K | Sell |
|
|||||
|
2022
Q1 | $1.23M | Sell |
|
|||||
|
2021
Q4 | $1.55M | Buy |
|
|||||
|
2021
Q3 | $940K | Hold |
|
|||||
|
2021
Q2 | $1.15M | Sell |
|
|||||
|
2021
Q1 | $3.87M | Buy |
|
|||||
|
2020
Q4 | $2.71M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.76M | Hold |
|
|||||
|
2020
Q1 | $1.63M | Buy |
|
|||||
|
2019
Q4 | $2.13M | Buy |
|
|||||
|
2019
Q3 | $1.75M | Buy |
|
|||||
|
2019
Q2 | $1.82M | Buy |
|
|||||
|
2019
Q1 | $1.43M | Hold |
|
|||||
|
2018
Q4 | $1.43M | Buy |
|
|||||
|
2018
Q3 | $1.53M | Buy |
|
|||||
|
2018
Q2 | $1.84M | Sell |
|
|||||
|
2018
Q1 | $1.31M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $100K | Hold |
|
|||||
|
2014
Q3 | $114 | Hold |
|
|||||
|
2014
Q2 | $155K | Buy |
|